All News about Alkermes Plc
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2024/07/24/xrdDAFhS-kD63I2-j45998648077-t23042711_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
6 Analysts Assess Alkermes: What You Need To Know
July 15, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
The Analyst Landscape: 7 Takes On Alkermes
June 17, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
6 Analysts Assess Alkermes: What You Need To Know
May 23, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/07/24/ATT-ATT.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/783372/july.jpeg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
7 Analysts Assess Alkermes: What You Need To Know
May 02, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600c.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Breaking Down Alkermes: 5 Analysts Share Their Views
April 09, 2024
Via Benzinga
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
The Analyst Verdict: Alkermes In The Eyes Of 4 Experts
March 19, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/Sleep.jpeg?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
A Look Into Healthcare Sector Value Stocks
March 11, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2017/05/IRU33.jpg)
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://www.chartmill.com/images/uploads/thumbnail_article_navellier_3be8c6e05a.webp)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.